Workflow optimization, increased efficiency and reduced errors in clinical trials

"It's a paradigm shift." This is how Prof. Ulf Teichgräber, Director of the Institute of Diagnostic and Interventional Radiology at the University Hospital Jena, describes the improvement in communication with sponsors and CROs through the use of mint Lesion™. Together, Ms. Laura Graziani, study coordinator, Ms. Elisabeth Lammers, study assistant/MTRA, and Prof. Teichgräber describe their journey towards a successful clinical trial center that can now manage up to 40 clinical trials simultaneously.
Where results previously had to be painstakingly entered into Excel spreadsheets, mint Lesion™ has taken over the evaluation of all findings since its introduction in 2015, thus increasing the objectivity and validity of the study results.

Related Resources

Related Resources

Medical personnel looking at a technical device to discuss diagnostic guidelines

2,237 Patients, 11 Hospitals, four HCC Criteria: A Comparison Study

A recent study, conducted across 11 South Korean hospitals, compared the diagnostic performance of four hepatocellular carcinoma (HCC) diagnostic…

mint Lesion screenshot with HCC diagnosis according to APASL, AASLD, LI-RADS, KLCA-NCC, and EASL guidelines

Comparison of Diagnostic Guidelines for Hepatocellular Carcinoma

Recent advancements in MRI techniques and tumor biology have led to updated hepatocellular carcinoma (HCC) diagnostic guidelines from various liver…

Alt text (EN) This picture shows several doctors looking at a medical image within the program mint Lesion™

On-Site BZKF BORN Roll-Out Trainings Keep on Going

Our expert Steffen Rupp recently visited the Technical University of Munich to continue the on-site BZKF BORN Roll-Out Trainings. As mentioned…